PRESTO study
Assoc. Prof. Aggarwal (US) talks about the main outcomes and safety profile of the PRESTO study of androgen annihilation in patients with high-risk biochemically relapsed prostate cancer and how this study translates into clinical practice.
Видео PRESTO study канала European Association of Urology
Видео PRESTO study канала European Association of Urology
Показать
Комментарии отсутствуют
Информация о видео
26 сентября 2022 г. 19:15:02
00:04:05
Другие видео канала
Coronavirus COVID-19 - Krankenhausaufenthalt
EAU18 - Interview with Ana Plata Bello
YAU Best Reviewer 2021 - Dr. R. (Riccardo) Campi
AI-derived digital pathology-based biomarker
Focus on Bladder Immunotherapy and the Young Patient
ACIS study
NABUCCO trial (cohort 2)
Biomarkers to guide active surveillance
De 4 fasen van geneesmiddelenonderzoek
EAU TV: Evaluating the effectiveness of treatment for clinically localised prostate cancer
EAU TV- First prize best video
What to expect at EAU22
Robot-geassisteerde Partiële Nefrectomie
Safety and efficacy of the erdafitinib intravesical delivery system: Phase 1: first-in-human study
CONTACT-03 study
EMUC18: Highlights of Active Surveillance consensus meeting in PCa
Is systemic therapy impactful for Renal Cell Carcinoma? An interview with Prof. Börje Ljungberg
EAU Prostate Cancer Research Award 2021 - Dr. W. (Wolfgang) Fendler
EAUTV: Infections at EAU23
EMUC18: STAMPEDE trial